Association of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) With an Increased Risk of Congestive Heart Failure in Hospitalized Patients With Cirrhosis: A Propensity Score-Matched Analysis
Ugwendum D, Mohamed M, Al-Ajlouni Y, Nso N, Njei B. Association of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) With an Increased Risk of Congestive Heart Failure in Hospitalized Patients With Cirrhosis: A Propensity Score-Matched Analysis. Cureus 2024, 16: e62441. PMID: 39011212, PMCID: PMC11249195, DOI: 10.7759/cureus.62441.Peer-Reviewed Original ResearchCongestive heart failureIn-Hospital MortalityCongestive heart failure riskOdds ratioMortality odds ratioCirrhotic patientsHeart failureClinical practice implicationsIn-patient mortalityLiver diseaseIncreased risk of congestive heart failureNational Inpatient SampleRisk of congestive heart failurePrevalence of congestive heart failureSteatotic liver diseaseHealth outcomesHospitalized cirrhotic patientsPost-matchPropensity Score Matching AnalysisHospital stay lengthStudy of patientsObese/overweight individualsInpatient SampleLogistic regressionDischarge status
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply